• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.72% Nasdaq Up 1.80%

    Athersys, Inc. (ATHX)

    -NasdaqCM
    1.25 Up 0.02(1.63%) 2:38PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:1.23
    Open:1.16
    Bid:1.30 x 100
    Ask:1.31 x 500
    1y Target Est:6.25
    Beta:0.15
    Earnings Date:Feb 2 - Feb 6 (Est.)
    Day's Range:1.16 - 1.43
    52wk Range:1.08 - 4.33
    Volume:747,459
    Avg Vol (3m):267,023
    Market Cap:96.89M
    P/E (ttm):N/A
    EPS (ttm):-0.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):41.31
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.32
    Quarterly EPS Est (Dec-14) :-0.10
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-0.14

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which has Phase I... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback